Cargando…

Humoral Immune Response to SARS-CoV-2 Vaccination after a Booster Vaccine Dose in Two Kidney Transplant Recipients with Fabry Disease and Variable Secondary Immunosuppressive Regimens

The urgent need to fight the COVID-19 pandemic has accelerated the development of vaccines against SARS-CoV-2 and approval processes. Initial analysis of two-dose regimens with mRNA vaccines reported up to 95% efficacy against the original strain of the SARS-CoV-2 virus. Challenges arose with the ap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bernea, Lavinia, Ailioaie, Oana R., Benhamouda, Nadine, Tartour, Eric, Germain, Dominique P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708799/ https://www.ncbi.nlm.nih.gov/pubmed/34960158 http://dx.doi.org/10.3390/vaccines9121412

Ejemplares similares

Enhanced Humoral Immune Response After COVID-19 Vaccination in Elderly Kidney Transplant Recipients on Everolimus Versus Mycophenolate Mofetil–containing Immunosuppressive Regimens
por: de Boer, Silke E., et al.
Publicado: (2022)

Humoral Response After SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Role of Immunosuppression Therapy
por: López, Verónica, et al.
Publicado: (2022)

Humoral and cellular response after BNT162b2 vaccine booster in hemodialysis patients and kidney transplant recipients
por: De Cagna, Maria Rosaria, et al.
Publicado: (2023)

Cellular and humoral immune response to SARS-CoV-2 vaccination and booster dose in immunosuppressed patients: An observational cohort study
por: Yang, Lu M., et al.
Publicado: (2022)

Longitudinal evaluation of the impact of immunosuppressive regimen on immune responses to COVID-19 vaccination in kidney transplant recipients
por: Wiedemann, Aurélie, et al.
Publicado: (2022)

Comparable cellular and humoral immunity upon homologous and heterologous COVID-19 vaccination regimens in kidney transplant recipients
por: Körber, Nina, et al.
Publicado: (2023)

Sustainability of humoral immunity induced by the SARS-CoV-2 vaccine and response to booster dose among Liver Transplant recipients
por: Rabinowich, Liane, et al.
Publicado: (2022)

Fabry disease
por: Germain, Dominique P
Publicado: (2010)

(1078) The Antibody Response of an MMF-Containing Immunosuppressive Regimen Aftercovid-19 Vaccination in Asian Heart Transplant Recipient
por: Tsao, C., et al.
Publicado: (2023)

(1197) Guillain-Barré Syndrome after Mrna-1273 Covid-19 Vaccine Booster in an Immunosuppressed Double Lung Transplant Recipient
por: Sindu, D., et al.
Publicado: (2023)

Belatacept-based immunosuppressive regimen in HIV-positive kidney transplant recipients
por: El Sakhawi, Karim, et al.
Publicado: (2020)

Humoral Immune Response to a Timely Booster mRNA Vaccination in Non-Responders to a Standard Vaccination Schedule against COVID-19 in Kidney Transplant Recipients
por: Stigler, Julia, et al.
Publicado: (2022)

Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients
por: Locke, Jayme E, et al.
Publicado: (2011)

Low switched memory B cells are associated with no humoral response after SARS-CoV-2 vaccine boosters in kidney transplant recipients
por: Seija, Mariana, et al.
Publicado: (2023)

Humoral response to heterologous prime‐booster vaccination in heart transplant recipients aged 18–70 years primed with a viral vector SARS‐CoV‐2 vaccine
por: Tanner, Richard, et al.
Publicado: (2022)

Humoral response to a fourth dose of mRNA vaccine in kidney transplant recipient responders to three doses of mRNA vaccine
por: de Nattes, Tristan, et al.
Publicado: (2022)

Immunogenicity and Safety of Beta-Adjuvanted Recombinant Booster Vaccine
por: Launay, Odile, et al.
Publicado: (2022)

Humoral response after a fourth “booster” dose of a Coronavirus disease 2019 vaccine following a 3-dose regimen of mRNA-based vaccination in dialysis patients
por: Housset, Pierre, et al.
Publicado: (2022)

Humoral and cellular immunogenicity of COVID-19 booster dose vaccination in inflammatory arthritis patients
por: Wroński, Jakub, et al.
Publicado: (2022)

Cellular and humoral responses to SARS-CoV-2 vaccination in immunosuppressed patients
por: Mohanraj, Dinesh, et al.
Publicado: (2022)

Predictors of Humoral Response to COVID-19 Vaccination in Heart Transplant Recipients
por: Memenga, F., et al.
Publicado: (2022)

Immunosuppressive regimens on conversion of cytomegalovirus infection to disease in liver transplant recipients
por: Rabbani, Amirhassan, et al.
Publicado: (2022)

COVID-19 vaccination in patients with multiple sclerosis: Safety and humoral efficacy of the third booster dose
por: Dreyer-Alster, Sapir, et al.
Publicado: (2022)

Humoral Response to Pfizer BNT162b2 Vaccine Booster in Maintenance Hemodialysis Patients
por: Shashar, Moshe, et al.
Publicado: (2022)

Evaluation of Humoral Response following SARS-CoV-2 mRNA-Based Vaccination in Liver Transplant Recipients Receiving Tailored Immunosuppressive Therapy
por: Manzia, Tommaso Maria, et al.
Publicado: (2023)

Early humoral response among lung transplant recipients vaccinated with BNT162b2 vaccine
por: Shostak, Yael, et al.
Publicado: (2021)

Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression
por: Prendecki, Maria, et al.
Publicado: (2021)

2367. Six-month Humoral Response Following Two Or Three Doses Of Covid-19 Vaccines As Primary Vaccination Followed Or Not By a Booster Dose In Specific Populations – ANRS0001S COV-POPART Cohort Study
por: LOUBET, Paul, et al.
Publicado: (2023)

Past COVID-19 and immunosuppressive regimens affect the long-term response to anti-SARS-CoV-2 vaccination in liver transplant recipients
por: Toniutto, Pierluigi, et al.
Publicado: (2022)

Humoral immunity in dually vaccinated SARS-CoV-2-naïve individuals and in booster-vaccinated COVID-19-convalescent subjects
por: Glück, Vivian, et al.
Publicado: (2022)

The SARS-CoV-2 Variant Omicron Is Able to Escape Vaccine-Induced Humoral Immune Responses, but Is Counteracted by Booster Vaccination
por: Hastert, Florian D., et al.
Publicado: (2022)

Impact of a booster dose on SARS-CoV2 mRNA vaccine-specific humoral-, B- and T cell immunity in pediatric stem cell transplant recipients
por: Thole, Linda Marie Laura, et al.
Publicado: (2023)

P1534: MRNA-1273 SARS-COV-2 VACCINE IN RECENTLY TRANSPLANTED ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: CELLULAR AND HUMORAL IMMUNE RESPONSES AND BOOSTER EFFECT
por: Albiol, Nil, et al.
Publicado: (2023)

Observations on improving COVID-19 vaccination responses in kidney transplant recipients: heterologous vaccination and immunosuppression modulation
por: Masset, Christophe, et al.
Publicado: (2022)

Characterization of humoral immune responses and degree of protection induced by influenza vaccine in cotton rats: Effects of low vaccine dose and single vs booster vaccination
por: Bhide, Yoshita, et al.
Publicado: (2020)

Durable spike-specific T cell responses after different COVID-19 vaccination regimens are not further enhanced by booster vaccination
por: Maringer, Yacine, et al.
Publicado: (2022)

Humoral immune response after different SARS-CoV-2 vaccination regimens
por: Rose, Ruben, et al.
Publicado: (2022)

Robust Humoral and Cellular Immune Responses to Pertussis in Adults After a First Acellular Booster Vaccination
por: van der Lee, Saskia, et al.
Publicado: (2018)

Humoral immunogenicity and reactogenicity of CoronaVac or ZF2001 booster after two doses of inactivated vaccine
por: Cao, Yunlong, et al.
Publicado: (2021)

Humoral response to SARS-CoV-2 after vaccination and booster effect in patients undergoing dialysis
por: Hernández-Porto, Miriam, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1ale2huse0u0gs84a8md4plbln